GILLIES MCINDOE RES INSTITUTE has a total of 20 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are TREOS BIO ZRT, HEBEI JUJING PHARMACEUTICAL CO LTD and OYAGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Brazil | 1 | |
#8 | Chile | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Itinteang Tinte | 19 |
#2 | Tan Swee Thong | 18 |
#3 | Davis Paul Frank | 18 |
#4 | Marsh Reginald Walter | 6 |
#5 | Baillie Ranui Francesca | 6 |
#6 | Swee Thong Tan | 1 |
#7 | Surman Peter | 1 |
#8 | Ranui Francesca Baillie | 1 |
#9 | Stanton Talyn | 1 |
#10 | Tinte Itinteang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020027665A1 | Novel pharmaceutical compositions for cancer therapy | |
CA3051840A1 | Cancer therapeutic | |
CA2959249A1 | Treatment of vascular anomalies | |
US2017360829A1 | Treatment of vascular anomalies | |
EP3384285A1 | Treatment of fibrotic conditions | |
US2017234884A1 | Cancer diagnosis and therapy |